Gsk Marketing Planning

4419 WordsMar 26, 201318 Pages
GSK Marketing Planning | March 31 2013 | Calvin Cheung, Hussain Al Katib, Manpreet Budwal, Sandra Okechukwu | SOSTAC Review based on GlaxoSmithKline | Content Table of Contents 1.0 Introduction2 2.0 Situation Analysis3 2.1 PESTEL Analysis3 2.2 SWOT Analysis4 2.3 Boston Matrix5 2.4 Porter’s Five Forces Analysis6 3.0 Objectives8 4.0 Strategy9 4.1 Product9 4.2 Price9 4.3 Promotion9 4.4 Place10 4.5 Person10 4.6 Process10 4.7 Physical Evidence10 5.0 Tactics11 6.0 Action Plan12 7.0 Control13 8.0 Summary13 9.0 References14 10.0 Appendices16 1.0 Introduction This assignment is a SOSTAC analysis for our marketing project with GSK whilst incorporating all things associated with SOSTAC. In this assignment we…show more content…
In general a new entrant may be faced by such barriers that have been put in place by established businesses; these could be: * Economies of scale ( Manufacturing, Research & Development, Marketing/ distribution, Sales) * Capital & Financial requirements * Product differentiation (Previous established products, brands and relationships) * Switching costs - employee retraining, new equipment, technical assistance For such reasons the barriers are high, meaning the threat of entry is low. GSK have significant manufacturing capabilities that are hard to replicate; they have patents to protect their products and they invariably have big marketing budgets designed to protect their brands. (Pharmaceutical&MedicalProfessionals, 2008) Threat: Low Bargaining power of suppliers: GSK’s main suppliers could be providers of many things. These could range from supplying raw materials, the manufacturing & production plants, the local co-marketing partners who supply the third party suppliers etc and labour. Suppliers can affect GSK in several ways: raising prices of raw materials; reducing quality of materials provided. These prospects could be vitally unattractive as it would impact the business’s profitability, having a major impact on
Open Document